Latest Breaking News On - Topline phase - Page 1 : comparemela.com

Ocular Therapeutix, Inc Announces Positive Topline Phase 1 Data for AXPAXLI? in Diabetic Retinopathy

Ocular Therapeutix, Inc. announced positive topline results from the Phase 1 HELIOS study evaluating AXPAXLI versus a sham control in patients with moderately severe to severe non-proliferative.

Ocular therapeutix incOcular therapeutixTopline phaseEfficacy resultsDiabetic retinopathy severity scaleNext steps

Ocular Therapeutix Announces Positive Topline Phase 1 Data for AXPAXLI in Diabetic Retinopathy

18.04.2024 - 46.2% of patients demonstrated a 1- or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks in the AXPAXLI arm, compared to 0% in the control arm No patients in the AXPAXLI group experienced worsening in DRSS compared to . Seite 1

Jeffreys heierOcular therapeutix incTopline phaseDiabetic retinopathy severity scaleChief scientific officer

Ocular Therapeutix (OCUL) Reports Positive Topline Phase 1 Data for AXPAXLI

Ocular Therapeutix (OCUL) Reports Positive Topline Phase 1 Data for AXPAXLI
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJeffreys heierDilsher dhootOcular therapeutix incOcular therapeutixTopline phaseDiabetic retinopathy severity scaleChief scientific officerCalifornia retina consultants

Ocular Therapeutix Reports Fourth Quarter and Full Year 2023 Results

11.03.2024 - Leadership Appointments Move Ocular Towards Being a Leader in Retinal Care Screening Underway in AXPAXLI Phase 3 SOL-1 Trial for Wet AMD Topline Clinical Data for AXPAXLI in Diabetic Retinopathy and PAXTRAVA in Glaucoma Expected in Q2 2024 Cash .

Jeff heierJoyce allaireDonald notmanSanjay nayakPravin dugelPeter kaiserOcular therapeutix incExchange commissionCash expectedSupport operations into at leastBalance plusGross proceedsInvestor dayOutline updated corporateExecutive chairmanChief scientific officer

Ocular Therapeutix™ Reports Fourth Quarter And Full Year 2023 Results

Ocular Therapeutix™ Reports Fourth Quarter And Full Year 2023 Results
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Jeff heierPravin dugelPeter kaiserJoyce allaireDonald notmanSanjay nayakExchange commissionOcular therapeutix incLeadership appointments move ocular towards beingClinical dataDiabetic retinopathyGlaucoma expectedSupport operations into at leastBalance plusGross proceedsInvestor day